Sierra D H, Feldman D S, Saltz R, Huang S
Department of Biomedical Engineering, School of Engineering, University of Alabama at Birmingham.
J Appl Biomater. 1992 Summer;3(2):147-51. doi: 10.1002/jab.770030210.
The adhesive strength of fibrin sealants has not been rigorously evaluated to date. The adhesive strength of six different concentrations of cryoprecipitated fibrinogen as well as the commercially available fibrin tissue adhesive Tissucol was tested under controlled conditions utilizing split-thickness skin grafts as the test adherand. This test configuration permitted the modeling of bonding strength for attachment of skin grafts as well as incorporate established engineering test standards for adhesives. An increase in fibrin concentration corresponded with an increase in shear adhesive strength. No significant increases in adhesive strength were attained after 5 min of bonding for all tested concentrations, except for the commercial adhesive, which attained the adhesive strength of an equivalent concentration of cryoprecipitated adhesive after 90 min. The adhesive strength, however, was an order of magnitude less than reported values of the tensile strength of fibrin material for similar concentrations. Therefore, it is important that the surgeon use a sufficiently high fibrinogen concentration for the specific clinical indication. The method of fibrin sealant preparation and/or the compounding adjuncts appear to have an effect on the development of adhesive strength.
迄今为止,纤维蛋白密封剂的黏附强度尚未得到严格评估。在可控条件下,以中厚皮片作为测试被粘物,测试了六种不同浓度的冷沉淀纤维蛋白原以及市售纤维蛋白组织黏合剂Tissucol的黏附强度。这种测试配置允许对皮肤移植附着的黏合强度进行建模,并纳入已确立的粘合剂工程测试标准。纤维蛋白浓度的增加与剪切黏附强度的增加相对应。除了市售黏合剂在90分钟后达到了与同等浓度冷沉淀黏合剂相同的黏附强度外,所有测试浓度在粘合5分钟后黏附强度均未显著增加。然而,对于相似浓度,其黏附强度比纤维蛋白材料拉伸强度的报告值低一个数量级。因此,外科医生针对特定临床指征使用足够高的纤维蛋白原浓度很重要。纤维蛋白密封剂的制备方法和/或复合辅料似乎对黏附强度的形成有影响。